講演情報
[O-21-4]Long-term safety and efficacy of zilucoplan in gMG: 120-week interim analysis of RAISE-XT [アンコール演題]
James F. Howard Jr.1, Miriam Freimer2, Angela Genge3, Channa Hewamadduma4,5, Yessar Hussain6, Angelina Maniaol7, Renato Mantegazza8, Kimiaki Utsugisawa9, Tuan Vu10, Michael D. Weiss11, Babak Boroojerdi12, Petra W. Duda12, Fiona Grimson12, Mark Vanderkelen12, M. Isabe Leite13 (1.Department of Neurology, The University of North Carolina at Chapel Hill, 2.Department of Neurology, The Ohio State University Wexner Medical Center, 3.Clinical Research Unit, The Montreal Neurological Institute, 4.Academic Neuroscience Unit, Sheffield Teaching Hospitals NHS Foundation Trust, 5.Sheffield Institute for Translational Neurosciences (SITraN), University of Sheffield, 6.Department of Neurology, Dell Medical School, The University of Texas at Austin, 7.Department of Neurology, Oslo University Hospital, 8.Department of Neuroimmunology and Neuromuscular Diseases, Fondazione IRCCS, Istituto Nazionale Neurologico Carlo Besta, 9.Department of Neurology, Hanamaki General Hospital, 10.Department of Neurology, University of South Florida Morsani College of Medicine, 11.Department of Neurology, University of Washington Medical Center, 12.UCB, 13.Nuffield Department of Clinical Neurosciences, University of Oxford)